In this interview, we delve into the remarkable journey of Professor Sir Peter Barnes, a leading figure in respiratory medicine.
#ASH24: Kura Oncology details ‘aggressive’ approach in first-line AML
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS